Ann: AGM Presentation, page-19

Great presentation! Apart from can't comment on medical speciality areas being a lay person, plus the highlighted "Existing commercial partnership with continued partnering negotiations with parties outside licensed territories", personally i like "Dimerix will continue to fund and execute the global ACTION3 Phase 3 study for DMX-200 in FSGS patients" especially as i recall i was watching an old (but excellent) interview by Nina at (late) pandemic period that she was already mentioning that there are trials/studies happening in many different countries/regions around the globe (13 countries from memory? i might be wrong here) which even from a lay person's perspective is a good thing (for potential future applications/commercialisation among those different regions and patients there) ?!